The 4th edition of the 3D Bioprinting Conference took place on January 31, 2017, at MECC Maastricht, The Netherlands.
The conference was part of a two-day event that included three other conferences and a dedicated exhibition. The conferences brought together over 230 attendees, who gathered to discuss the most disruptive applications of 3D printing in the medical world, and latest developments and applications in the field. They were not purely academic conferences, but innovative events bringing together brilliant minds and discoveries.
At the 3D Bioprinting Conference, speakers from University of Cambridge, iMakr, University of Pennsylvania School of Veterinary Medicine New Bolton Center,University of Zurich / Braunpat Braun Eder AG, InnoPhysics, BioDan Group, Université Lyon1, University of Erlangen-Nuremberg and University of Manchester talked about the topics in focus.
The titles of the presentations included: High resolution biomaterial printing via low-voltage electrospinning patterning; How to go about de-risking an emerging technology all the way to regulatory submission; Challenges in Patenting Bioartificial Organs; μPlasmaPrint : digital on-demand surface engineering; Additive Manufacturing of functionally graded scaffolds for bone tissue engineering; 3d.FAB platform: 3D printing for life science; Biofabrication of hard and soft matrix for bone tissue regeneration; 3D Bioprinting: Ethical Aspects and the Big Picture; What is possible with bioprinting?
Fast facts about the importance of 3D Bioprinting
3D printing is becoming increasingly implemented in the operating room, with surgeons turning to the technology to create tailor-made implants for their patients. Several uses of the technology are already generating revenue as viable medical businesses, like dental applications, prosthetics and hearing devices.
The most disruptive application of 3D printing in the medical world might be bioprinting – the production of human organs for transplant or for body on a chip use. The technology involves the creation of replacement tissues and organs that are printed layer-by-layer into a three-dimensional structure.
This rapidly developing market raises many questions. Which technologies are developed yet? What are the costs of the production of bioprinted tissues and organs? Which effects does tissue engineering cause? Which markets are influenced by the innovative 3D printing technologies? And how quickly can those customized products be manufactured? The 3D Bioprinting Conference gives answers to these kinds of questions.
Who should attend the next edition?
The audience is a mix of academics, business, technology, regulation and creative, so the content will address both professionals and enthusiasts in the field. Accordingly, the conference is of interest for any person involved in health care innovation, from surgeon to biomedical engineer, from researcher to dentist and from hardware manufacturer to bio medical material researcher.
The conference is part of the 3D Medical Expo, an event that includes a two-day exhibition and three other conferences besides the 3D Bioprinting: